China Grand Pharma acquires majority shares of US-based OncoSec Medical

Hong Kong-listed company Grand Pharma announced that it has completed the acquisition of shares of the NASDAQ-listed company OncoSec Medical.
After the completion of the transaction, Grand Pharma and the Sirtex Group jointly acquired by CDH Investment and Grand Pharma will hold a total of 52.8% of OncoSec shares. Among them, Grand Pharma holds 44% and Sirtex 8.8%.

Hong Kong-listed company Grand Pharma announced that it has completed the acquisition of shares of the NASDAQ-listed company OncoSec Medical.

After the completion of the transaction, Grand Pharma and the Sirtex Group jointly acquired by CDH Investment and Grand Pharma will hold a total of 52.8% of OncoSec shares. Among them, Grand Pharma holds 44% and Sirtex 8.8%.

OncoSec is a high-tech innovative biotechnology company that has entered the clinical stage and has strong research and development strength in the field of tumor immunity and intervention.

As a potential treatment for multiple cancer indications, OncoSec’s core product TAVO can be used as a monotherapy or in combination with leading checkpoint inhibitors (such as PD-1 / PD-L1, etc.), which is expected to meet unmet medical needs in oncology. Currently, TAVO has the exclusive commercialization rights in China and other 38 Asian regions.

As the new development of Grand Pharma in the field of global innovation, the synergy between OncoSec and previously acquired Sirtex has become one of the highlights of this transaction.

At the same time, with the mature global sales network of the Sirtex Group, the Sirtex Group will support and assist OncoSec’s TAVO and VLA in the promotion of all products in Europe and the United States and other markets, which will help OncoSec’s products to quickly expand the global market.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/05/china-grand-pharma-acquires-majority-shares-of-us-based-oncosec-medical/.

Leave a Reply

Please Login to Comment